Multi-Cancer Detection Observational Cohort Study

Mayo Clinic

Status: Enrolling

Conditions: Cancer

Treatments: Procedure: Blood Sample; Other: Surveys

Study type: Observational

Funder types: Other

Identifiers

NCT06962995

24-000321

NCI-2025-03276 (Registry Identifier)

Details and patient eligibility

About

This study assesses the incorporation of Multi-Cancer Detection (MCD) testing, designed to detect many types of cancer, into clinical practice to understand both its use and effect in real world practice conditions.

Enrollment: 500 estimated patients

Sex: All

Ages: 21+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Has Mayo Clinic medical record number
• Has undergone (within last 6 months) or scheduled to undergo a multi-cancer detection test (MCD) as ordered by provider
• Able to provide informed consent
• ≥ 21 years old
• Ability to provide blood sample

Exclusion criteria

• Individuals who have situations that would limit compliance with the study requirements
• Institutionalized (i.e. Federal Medical Prison)
• Known pregnancy (self-reported)
• Currently undergoing active cancer treatment other than adjuvant hormone therapy
• Invasive cancer diagnosis within the last 3 years

Trial design

500 participants in 1 patient group

Observational

Description:

Patients complete surveys and have their medical records reviewed on study. Patients may undergo blood or buccal swab and urine sample collection on study.

Treatment:

Other: Surveys

Procedure: Blood Sample